On science: McCain v. the GOP

When it comes to matters of science, Republican US presidential hopeful John McCain is with his party on some issues, not quite on others. This week the Republican Party released linkurl:a draft of;http://www2.nationalreview.com/dest/2008/08/25/fulldraftaug25.pdf its 2008 platform, one that will be debated in the days leading up to the GOP convention in St Paul, Minnesota, starting Monday (September 1). Some of the party's points regarding science differ from the campaign points McCain has been running on for more than a year. While McCain and his party agree that federal dollars should be spent on supporting biomedical research, the rub is certainly linkurl:embryonic stem cell research.;http://www.the-scientist.com/blog/display/54544/ McCain openly supports work with embryonic stem cells, whereas the party platform calls for an expansion of stem cell research, with a focus on sources such as umbilical cord blood and linkurl:reprogrammed pluripotent;http://www.the-scientist.com/blog/display/54918/ (iPS) cells. Both oppose human cloning and the creation of human embryos for research purposes. Another major difference is how McCain has proposed to confront linkurl:global warming.;http://www.the-scientist.com/article/display/54049/ The party's stance is that technological developments and market-based solutions will lead to lower emissions; they oppose government regulations and would offer cash prizes for innovation. McCain on the other hand has outlined a cap and trade system to be applied to commercial and industrial businesses. Under this plan entities would be able to buy and sell rights to emit, with limits on total emissions. Despite the differences in stance, McCain's aides linkurl:told Bloomberg News;;http://www.bloomberg.com/apps/news?pid=newsarchive&sid=ahIrsc3U8e9E that they don't plan to fight the party over platform positions. Official party platforms are not binding, and candidates are not required to adhere to them, but rather form their own policies. For a peek at some of the science advocates who may be whispering in the ear of the next president, stay tuned for a feature appearing in the September issue of The Scientist.

On science: McCain v. the GOP

The Scientist ARCHIVES

Become a Member of

Meet the Author

Andrea Gawrylewski

Related Research Resources

Study Confirms Safety of Genetically Modified T Cells

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Making Real-Time PCR More Straightforward

Characterizing Immune Memory to COVID-19 Vaccination

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Products

Product News

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

Agilent BioTek Cytation C10 Confocal Imaging Reader

Sapio Sciences Introduces Biorepository Management Solution